The Medical Grand Rounds on Review of the expanding roles of SGLT2 inhibitors
was held on October 14, 2021
was Dr. Shervin Zandi, Assistant Clinical Professor, Department of Medicine.
Review the evidence of SGLT2 inhibitors in: Diabetes, Heart Failure, Chronic Kidney Disease & Special considerations/precautions of SGLT2 inhibitors.
Please see the presentation on YouTube Channel
of the Department of Medicine.